Nu Skin Enterprises Inc Class A (NUS) financials
Nu Skin Enterprises revenue and earnings by year
Nu Skin Enterprises's revenue was $1.49 billion in the fiscal year to December 31, 2025, down 14.3% from the year before. Net income was $160 million, 10.8% of revenue. Since the fiscal year to December 31, 2016, revenue has shrunk 4.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.49 | 1.73 | 1.97 | 2.23 | 2.70 | 2.58 | 2.42 | 2.68 | 2.28 | 2.21 |
| Revenue growth | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% | 6.7% | -9.7% | 17.5% | 3.2% | — |
| Gross profit | 1.03 | 1.18 | 1.36 | 1.59 | 2.02 | 1.92 | 1.84 | 2.04 | 1.78 | 1.71 |
| Gross margin | 69.4% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | 77.3% |
| Operating income | 0.07 | -0.15 | 0.05 | 0.11 | 0.23 | 0.26 | 0.27 | 0.24 | 0.27 | 0.23 |
| Operating margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.0% | 9.0% | 12.0% | 10.5% |
| Net income | 0.16 | -0.15 | 0.01 | 0.10 | 0.15 | 0.19 | 0.17 | 0.12 | 0.13 | 0.14 |
| Net margin | 10.8% | -8.5% | 0.4% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | 6.5% |
| Diluted EPS | $3.18 | -$2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 |
| Free cash flow | 0.05 | 0.07 | 0.06 | 0.05 | 0.07 | 0.32 | 0.11 | 0.13 | 0.24 | 0.23 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open NUS in Markets.
How Nu Skin Enterprises makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Americas | $59.8M | 18.7% |
| Manufacturing | $46.4M | 14.5% |
| Mainl & China | $46.0M | 14.4% |
| Southeast Asia Pacific | $43.3M | 13.5% |
| Japan | $38.1M | 11.9% |
| Europe & Africa | $32.3M | 10.1% |
| Hong Kong Taiwan | $26.1M | 8.1% |
| South Korea | $25.6M | 8.0% |
| Rhyz Other | $2.53M | 0.8% |
See also: NUS valuation and P/E history · NUS returns
No forecast, no recommendation. This page describes Nu Skin Enterprises Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.